ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and pote… Read more
ANI Pharmaceuticals Inc (ANIP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.056x
Based on the latest financial reports, ANI Pharmaceuticals Inc (ANIP) has a cash flow conversion efficiency ratio of 0.056x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($30.37 Million) by net assets ($540.72 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ANI Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how ANI Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ANI Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ANI Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kohl's Corporation
NYSE:KSS
|
0.032x |
|
Perrigo Company PLC
NYSE:PRGO
|
0.012x |
|
MAKINO MILLG MACH.
F:95B
|
N/A |
|
Banpu Public Company Limited
BK:BANPU
|
0.018x |
|
Guangdong Shenling Environmental Systems Co. Ltd.
SHE:301018
|
0.040x |
|
Guangzhou Baiyun International Airport Co Ltd
SHG:600004
|
0.053x |
|
Arcplus Group PLC
SHG:600629
|
0.035x |
|
IBF Financial Holdings Co Ltd
TW:2889
|
-0.047x |
Annual Cash Flow Conversion Efficiency for ANI Pharmaceuticals Inc (1998–2025)
The table below shows the annual cash flow conversion efficiency of ANI Pharmaceuticals Inc from 1998 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $540.72 Million | $185.22 Million | 0.343x | +129.30% |
| 2024-12-31 | $428.53 Million | $64.02 Million | 0.149x | -42.54% |
| 2023-12-31 | $457.60 Million | $118.96 Million | 0.260x | +382.05% |
| 2022-12-31 | $338.54 Million | $-31.20 Million | -0.092x | -1095.33% |
| 2021-12-31 | $358.74 Million | $3.32 Million | 0.009x | -88.13% |
| 2020-12-31 | $195.70 Million | $15.27 Million | 0.078x | -63.62% |
| 2019-12-31 | $212.79 Million | $45.63 Million | 0.214x | -36.93% |
| 2018-12-31 | $197.26 Million | $67.07 Million | 0.340x | +50.74% |
| 2017-12-31 | $174.76 Million | $39.42 Million | 0.226x | +39.29% |
| 2016-12-31 | $169.65 Million | $27.47 Million | 0.162x | +50.16% |
| 2015-12-31 | $160.08 Million | $17.26 Million | 0.108x | -31.58% |
| 2014-12-31 | $139.78 Million | $22.03 Million | 0.158x | +217.73% |
| 2013-12-31 | $40.96 Million | $-5.48 Million | -0.134x | +85.08% |
| 2012-12-31 | $28.18 Million | $-25.28 Million | -0.897x | +29.11% |
| 2011-12-31 | $37.82 Million | $-47.87 Million | -1.266x | +39.55% |
| 2010-12-31 | $19.15 Million | $-40.10 Million | -2.094x | -79.87% |
| 2009-12-31 | $15.83 Million | $-18.43 Million | -1.164x | -3.62% |
| 2008-12-31 | $13.83 Million | $-15.54 Million | -1.124x | -4613.67% |
| 2007-12-31 | $29.73 Million | $739.99K | 0.025x | +109.00% |
| 2006-12-31 | $18.07 Million | $-5.00 Million | -0.277x | +77.28% |
| 2005-12-31 | $6.82 Million | $-8.30 Million | -1.217x | -85.52% |
| 2004-12-31 | $15.92 Million | $-10.44 Million | -0.656x | -3.15% |
| 2003-12-31 | $8.68 Million | $-5.52 Million | -0.636x | +25.81% |
| 2002-12-31 | $4.62 Million | $-3.96 Million | -0.857x | -90.38% |
| 2001-12-31 | $4.05 Million | $-1.82 Million | -0.450x | +70.17% |
| 2000-12-31 | $2.13 Million | $-3.21 Million | -1.509x | -360.05% |
| 1999-12-31 | $5.45 Million | $-1.79 Million | -0.328x | +71.62% |
| 1998-12-31 | $2.63 Million | $-3.04 Million | -1.156x | -- |